NewGenIVF Announces Its 13% Stake In K25.ai Is Now Valued At ~$26M, Generating Expected Unrealized Gain Of ~$8.5M
NewGenIvf Group Limited Class A NIVF | 0.00 |
NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company’s capitalization and financial position.
NewGen reported net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025, with net assets of approximately US$25.98 million as of that date. The Company’s financial position has been further strengthened in 2026 by the appreciation in value of its investment in K25.ai.
Based on a current implied valuation of US$200 million for K25.ai, the Company’s agreed 13% stake, which remains subject to completion of the acquisitions in accordance with the applicable share purchase agreements, is now valued at approximately US$26 million, generating an expected unrealized gain of approximately US$8.5 million. The Company believes this appreciation represents a meaningful enhancement to its balance sheet and reflects the continued growth trajectory of K25.ai since the initial investment was made.
Upon completion of the issuance of 2,500,000 Class A ordinary shares as announced on July 27, 2026, NewGen’s total outstanding Class A ordinary share count is expected to reach approximately 5,900,000.
